Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1 1

Status

Unknown 3Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Thoracic 4Other hematologic neoplasm 4Gastrointestinal 4Breast 4Tumor-Agnostic 2Other solid neoplasm 2Gynecologic 2Sarcoma 1Myeloid 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Antineoplastic Agents × Thoracic × Clear all
NCT06357598 2024-04-10

PILOT

The Affiliated Hospital of Qingdao University

Phase 4 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05573373 2024-01-31

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

Affiliated Hospital of Jiangnan University

Phase 1 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04943029 2021-09-02

NEOSUN

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00617409 2019-11-08

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
69 enrolled 10 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡